Resources

Large-scale food fortification (LSFF) has emerged as an important strategy for addressing micronutrient deficiencies and improving nutrition at population scale. Yet, translating policy commitments into effective, sustainable programs requires more than establishing fortification standards. It depends on strong regulatory and quality assurance systems, capable local industries, reliable supply chains, effective monitoring, and the ability to reach populations through existing public platforms. Across Africa, Asia, and Latin America, countries have developed diverse approaches to addressing these challenges, offering valuable lessons for others navigating similar pathways. This report brings together evidence and experiences from 16 countries to highlight what is working, where gaps remain, and how countries can learn from one another to strengthen more sustainable and locally owned approaches to LSFF.

Respiratory syncytial virus (RSV) is a major, under–recognized public health problem causing more severe respiratory infections and hospitalizations in infants and young children each year than any other pathogen. New immunization tools now recommended for global use by the World Health Organization (WHO) could help change that.The opportunity to address this pervasive virus has never been better. To raise awareness, WHO and PATH have developed a toolkit of communication materials that public health stakeholders and advocates can use to share information about RSV disease, new prevention tools, and delivery considerations. Other expert contributors include the US Centers for Disease Control and Prevention, Seattle Children's Hospital/University of Washington, UMC Utrecht, the International Vaccine Access Center (IVAC), RRD Design, and more.To accommodate varying audience and engagement needs, this toolkit includes a stand-alone RSV primer presentation (and fact sheet) providing an overview of RSV disease and prevention options. Also available are modular PowerPoint slides that can be mixed and matched with the primer presentation to dive deeper into key topics for informing understanding and decision-making around RSV prevention. All slides come with speaker notes.Additional social media tools make sharing information about RSV with your network easy!To learn more about the toolkit, visit the web page.NOTE: Files available here as read-only. Editable files are readily available upon request. Please contact us.

Additional contraceptive options are needed to expand the availability, accessibility, and acceptability of long-acting contraception globally. Microneedle array patches (MAPs) are a novel drug delivery system with the potential to help address this need. Regulatory guidance applicable to this novel delivery system is limited, and no drug-containing MAPs have been granted marketing authorization to date in any health area. To support the timely and streamlined development of long-acting LNG MAPs in the absence of regulatory precedent, PATH sought product-agnostic regulatory scientific advice from agencies recognized as operating at an advanced level of performance. The white paper, Advancing Long-Acting Levonorgestrel Microneedle Array Patches: Early Regulatory Insights to Guide Development, summarizes the scientific advice received from the agencies and contextualizes its implications for advancing LNG MAP development.

The World Bank Group’s GFF × CIVIC partnership—a joint initiative of the Global Financing Facility for Women, Children and Adolescents (GFF) and the CIVIC: The Civil Society and Social Innovation Alliance—is supporting a consortium led by PATH, in partnership with the African Institute for Development Policy (AFIDEP) and the Organisation of African Youth (OAY), working together as VOICES (Voices Organizing for Inclusive Civic Engagement and Sustainability) to strengthen civil society engagement, coalition-building, and youth leadership around domestic resource mobilization for women’s, children’s and adolescent health and nutrition.To advance these objectives, the VOICES consortium will award subgrants to local CSOs and youth-led organizations in up to 22 African countries. Local CSOs and youth-led organizations are invited to apply as advocacy partnerships and help drive sustainable, accountable health investment for women, children, and adolescents.Learn more about the funding opportunity—with information available in English, French, and Portuguese—and contact us at voices@path.org with any questions. Applications closed on Wednesday, October 7th, 2026 at 23:59 East Africa Time. Results will be announced in November.

This tool is designed to help global health stakeholders, procurers, and advocates estimate the annual operating expenditures (OPEX) of pressure swing adsorption (PSA) oxygen plants in low- and middle-income countries (LMICs). It is intended to support advocacy, planning, and comparative analysis related to oxygen system investments.The tool generates approximate operating cost estimates based on key PSA plant specifications and operating assumptions. Users should complete all input fields to the best of their ability using information available for the plant being assessed. Suggested values are provided for selected inputs to support users when site-specific information is unavailable.The estimates produced by this tool are intended to provide a standardized, evidence-informed basis for discussion and comparison across settings. The tool is not intended to serve as a detailed budgeting, procurement, or financial planning tool.